2026 Best Value Clinical and Industrial Drug Development Schools
[Clinical and Industrial Drug Development](/majors/health-care-professions/pharmacy-pharmaceutical-sciences/clinical-and-industrial-drug-development/) degree programs vary widely in price and payoff across the country. The best values balance affordable tuition against strong post-graduation earnings.
For its 2026 best-value ranking, College Factual looked at 14 schools to find the best return on investment for clinical and industrial drug development students.
What’s on this page:
Finding the Best Value Clinical and Industrial Drug Development School for You
Where you study clinical and industrial drug development affects both what you pay and what you earn. To help, we created our Best Value Clinical and Industrial Drug Development Schools ranking. It weighs the cost of a degree against the outcomes graduates go on to achieve, so you can find the strongest return on your investment.
Learn more about our methodology
Customizing Your List
Since the program you select can have a significant impact on your future, we offer several rankings, including this Best Value Clinical and Industrial Drug Development Schools list, to help you choose. More interested in schools in a specific area of the country? Filter this list by region or state.
To further help you make the college decision, we have developed a unique tool called College Combat that lets you compare schools on the factors that matter most to you.
Read more about College Factual’s methodology
2026 Best Value Clinical and Industrial Drug Development Schools in the United States
Below are the schools that deliver the strongest value in clinical and industrial drug development, balancing cost against outcomes.
Best Value Clinical and Industrial Drug Development Schools
John Tyler Community College earned the #1 spot for value among clinical and industrial drug development schools in the United States. Located in the suburb of Chester, John Tyler Community College is a large public university. The average in-state cost of tuition and fees is $5,082, with out-of-state students paying around $11,520. Students borrow a median of $11,262 to complete the clinical and industrial drug development program here. Early-career clinical and industrial drug development graduates make about $36,623. Set against $11,262 in median debt, that is a healthy payoff.
A rank of #2 makes University Of California San Diego one of the best values for clinical and industrial drug development. Set in the city of La Jolla, University Of California San Diego is a very large public institution. In-state tuition and fees average $15,788, while out-of-state students pay about $47,676. Typical student debt for clinical and industrial drug development graduates is $17,101. Soon after graduation, clinical and industrial drug development degree recipients from University Of California San Diego generally make around $113,226. Set against $17,101 in median debt, that is a healthy payoff. University Of California San Diego admits about 27% of applicants.
Students looking for strong value in clinical and industrial drug development will find it at University Of Washington Seattle Campus, which ranked #3. Located in the city of Seattle, University Of Washington Seattle Campus is a very large public university. Students from in state pay about $12,973 in tuition and fees, with out-of-state students paying around $43,209. Typical student debt for clinical and industrial drug development graduates is $16,481. Clinical And Industrial Drug Development graduates of University Of Washington Seattle Campus earn a median of $109,852 early in their careers. Weighed against typical debt, the earnings make a compelling case for value. Roughly 39% of applicants are accepted.
Students looking for strong value in clinical and industrial drug development will find it at University Of Georgia, which ranked #4. Set in the city of Athens, University Of Georgia is a very large public institution. In-state tuition and fees average $11,450, compared with $31,688 for out-of-state students. Typical student debt for clinical and industrial drug development graduates is $23,761. Early-career clinical and industrial drug development graduates make about $114,226. That is a strong return on a $23,761 median debt. The acceptance rate is 38%.
University Of Rhode Island came in at #5 on our 2026 list of the best value clinical and industrial drug development schools. Set in the suburb of Kingston, University Of Rhode Island is a very large public institution. Students from in state pay about $16,942 in tuition and fees, compared with $37,146 for out-of-state students. Clinical And Industrial Drug Development graduates carry a median of $23,432 in student loans. Clinical And Industrial Drug Development graduates of University Of Rhode Island earn a median of $52,821 early in their careers. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 72%.
University Of Cincinnati Main Campus came in at #6 for value in clinical and industrial drug development this year. University Of Cincinnati Main Campus is a very large public school located in the city of Cincinnati. In-state tuition and fees average $13,363, with out-of-state students paying around $28,697. Typical student debt for clinical and industrial drug development graduates is $23,530. Soon after graduation, clinical and industrial drug development degree recipients from University Of Cincinnati Main Campus generally make around $103,717. That is a strong return on a $23,530 median debt. The acceptance rate is 85%.
Campbell University earned the #7 position for value in clinical and industrial drug development this year. Located in the town of Buies Creek, Campbell University is a moderately-sized private not-for-profit university. In-state tuition and fees average $41,600. Students borrow a median of $23,065 to complete the clinical and industrial drug development program here. Clinical And Industrial Drug Development graduates of Campbell University earn a median of $77,265 early in their careers. Set against $23,065 in median debt, that is a healthy payoff. Campbell University admits about 87% of applicants.
Temple University placed #8 among the best values for clinical and industrial drug development. Set in the city of Philadelphia, Temple University is a very large public institution. In-state tuition and fees average $23,005, compared with $38,805 for out-of-state students. Clinical And Industrial Drug Development graduates carry a median of $26,259 in student loans. Clinical And Industrial Drug Development graduates of Temple University earn a median of $111,896 early in their careers. Weighed against typical debt, the earnings make a compelling case for value. Roughly 80% of applicants are accepted.
University Of Southern California came in at #9 for value in clinical and industrial drug development this year. Located in the city of Los Angeles, University Of Southern California is a very large private not-for-profit university. The average in-state cost of tuition and fees is $71,647. Typical student debt for clinical and industrial drug development graduates is $15,625. Clinical And Industrial Drug Development graduates of University Of Southern California earn a median of $114,101 early in their careers. Set against $15,625 in median debt, that is a healthy payoff. Roughly 10% of applicants are accepted.
Narrow Clinical and Industrial Drug Development Schools by Region
View All Rankings >
Explore other best-value rankings in majors related to Clinical and Industrial Drug Development. Browse the parent area of study.
Notes and References
This ranking is produced by College Factual (MF_RANKING_2025), 2026 edition. Schools are scored on the balance of cost (tuition and student debt) against student outcomes (post-graduation earnings) — a measure of return on investment, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 14 schools evaluated.
*Averages shown above reflect the top 6 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.
